These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1398853)

  • 1. Circulating immune complexes in leukaemias and lymphomas.
    Kishore J; Kumar R; Choudhry VP; Bhargava M
    Indian J Pediatr; 1992; 59(2):225-31. PubMed ID: 1398853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes in patients with lymphomas and leukemias.
    Patel GV; Gopal R; Nadkarni JJ
    Neoplasma; 1984; 31(2):197-202. PubMed ID: 6585680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow-cytometric analysis of lymphocytes, leukaemias and lymphomas.
    Macey MG
    Br J Biomed Sci; 1993 Dec; 50(4):334-49. PubMed ID: 8130695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination of leukemias, lymphomas, and non-neoplastic controls by retroviral serum markers.
    Hehlmann R; Schreiber MA; Kreeb G; Erfle V; Weber W; Obrecht P
    Haematol Blood Transfus; 1985; 29():207-14. PubMed ID: 4029730
    [No Abstract]   [Full Text] [Related]  

  • 5. EBV infections in Brazil. I. Occurrence in normal persons, in lymphomas and in leukemias.
    Carvalho RP; Evans AS; Frost P; Dalldorf G; Camargo ME; Jamra M
    Int J Cancer; 1973 Jan; 11(1):191-201. PubMed ID: 4364322
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of circulating immune complexes in hemolymphopathies].
    Delsignore R; Baroni MC; Mineo F; Crotti G; Butturini U
    G Clin Med; 1984; 65(3-4):157-62. PubMed ID: 6588012
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray.
    Belov L; Mulligan SP; Barber N; Woolfson A; Scott M; Stoner K; Chrisp JS; Sewell WA; Bradstock KF; Bendall L; Pascovici DS; Thomas M; Erber W; Huang P; Sartor M; Young GA; Wiley JS; Juneja S; Wierda WG; Green AR; Keating MJ; Christopherson RI
    Br J Haematol; 2006 Oct; 135(2):184-97. PubMed ID: 16939496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune complexes in human malignant tumours. A review.
    Segal-Eiras A; Croce MV
    Allergol Immunopathol (Madr); 1984; 12(3):225-32. PubMed ID: 6382986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunological diagnosis of human leukemias and lymphomas: an overview.
    Seligmann M; Brouet JC; Preud'Homme JL
    Haematol Blood Transfus; 1977; 20():1-16. PubMed ID: 344161
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality assessment for immunophenotyping of leukaemias and lymphomas: the Dutch experience. The SIHON Study Group.
    van't Veer MB; Gratama JW
    Leuk Lymphoma; 1994; 13 Suppl 1():77-9. PubMed ID: 8075586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of circulating immune-complexes as prognostic indicators of lympho-reticular and mesenchymal malignancies in children.
    Aziz M; Dass TK; Rattan A
    J Trop Pediatr; 1992 Aug; 38(4):185-8. PubMed ID: 1527815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of viral antigen p24 in circulating immune complexes of two patients with human T-cell leukaemia/lymphoma virus (HTLV) positive lymphoma.
    Schüpbach J; Kalyanaraman VS; Sarngadharan MG; Bunn PA; Blayney DW; Gallo RC
    Lancet; 1984 Feb; 1(8372):302-5. PubMed ID: 6141379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B & T markers in leukemia and lymphoma.
    Bloomfield CD
    Minn Med; 1979 Jul; 62(7):499-501. PubMed ID: 315029
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemical evaluation of hematologic malignancies.
    Miettinen M; Schwarting R; Hyun BH
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):683-701. PubMed ID: 7961286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality assessment of immunological marker analysis and the immunological diagnosis in leukaemia and lymphoma: a multi-centre study. Dutch Cooperative Study Group on Immunophenotyping of Leukaemias and Lymphomas (SIHON).
    van't Veer MB; Kluin-Nelemans JC; van der Schoot CE; van Putten WL; Adriaansen HJ; van Wering ER
    Br J Haematol; 1992 Apr; 80(4):458-65. PubMed ID: 1581230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of haematological malignancies and their treatment on host defence factors.
    Hersh EV; Gutterman JU; Mavligit GM
    Clin Haematol; 1976 Jun; 5(2):425-48. PubMed ID: 780032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunophenotyping of leukemia: overview].
    Huber K; Worofka B; Kittl E; Tomasits J; Hofmann J; Bauer K
    Wien Klin Wochenschr; 1994; 106(8):226-30. PubMed ID: 8023514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation if circulating immune complexes and disease status in patients with leukaemia.
    Hubbard RA; Aggio MC; Lozzio BB; Wust CJ
    Clin Exp Immunol; 1981 Jan; 43(1):46-53. PubMed ID: 7249393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circulating immune complexes of patients with malignant lymphomas (author's transl)].
    Sodomann CP; Schmidt H; Havemann K
    Blut; 1979 Jun; 38(6):435-46. PubMed ID: 444682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulating immune complexes in human leukemias].
    Carpentier NA; Zubler RH; Lange GT; Lambert PH; Miescher PA
    Schweiz Med Wochenschr; 1976 Oct; 106(40):1363-4. PubMed ID: 1070156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.